Canadian Journal of Diabetes: Diabetes Care & Translational Research (Including Canadian Population

1. 领域背景与期刊定位

The 2024-2025 diabetes research landscape prioritizes three core directions: AI-driven personalized glucose management, SGLT2 inhibitor applications for cardiovascular/renal comorbidities, and real-world evidence (RWE) for healthcare policy optimization.投稿痛点: 65% of submissions to regional diabetes journals are rejected due to insufficient clinical translation or lack of relevance to local healthcare systems ^中科院文献情报中心2025^.

Journal Positioning:

-主办机构: Diabetes Canada (formerly Canadian Diabetes Association)
-创刊时间: 1977
-收稿特色: A clinical-translational journal focusing on diabetes care, epidemiology, pathophysiology, and public health—with a strong emphasis on Canadian context (e.g., Indigenous diabetes disparities, Canada’s national diabetes strategy impact). It accepts original research (clinical/translational), reviews, case reports (rare complications), editorials, and letters.

• Mega Journal Status: No (annual publication volume ~180 papers, 2024 data).

This journal is ideal for researchers targeting regional clinical practice implications or studies on Canadian diabetes populations.

2. Core Data Analysis: 2024 Impact Factor & Partitioning

Note: 2025 JCR/中科院分区 data not yet released (as of June 2025). Below are 2024 historical data:

Evaluation Dimension	Specific Data	Remarks (2025 Reform Links)
JCR Impact Factor (JIF)	4.2 (2024), up 10.5% from 2023 (3.8)	2025 JIF will exclude撤稿引用 (potential minor fluctuation)
JCR Partition (Subclass/Class)	Subclass: Endocrinology & Metabolism Q3; Class: Clinical Medicine Q3	Ranked 120/195 in Endocrinology & Metabolism (2024)
中科院分区 (Subclass/Class)	Subclass: Diabetes 4区; Class: Clinical Medicine 4区	Based on "Journal Exceedance Index" (2024)
Self-Citation Rate	5.1% (2024)	Well below 20% risk threshold
Review Cycle	Average first decision: 45 days; Overall acceptance cycle: 120 days	From 2024 Author Guidelines

Data Interpretation:

• The 2024 JIF growth reflects increased citations of its clinical translation studies.
• Suitable for: Early-career researchers (graduate students/postdocs) seeking regional recognition, or clinicians submitting real-world Canadian diabetes data.
• 2025 Reform Note: Since its self-citation rate is low, the 2025 JIF is unlikely to be affected by the撤稿引用 exclusion rule.

3. Submission Guide: Key Notes & Practical Tips

(1) Pre-Submission Basics

Scope Matching:

• Accepted: Original clinical/translational research (with Canadian relevance), reviews (systematic or narrative), rare case reports (e.g., diabetic ketoacidosis in pediatric Type 1), editorials.
• Rejected: Pure basic science without clinical links, studies unrelated to diabetes, or global studies with no implications for Canadian healthcare.
• Tool: Use JANE (Journal/Author Name Estimator) to match keywords like "Indigenous diabetes Canada" or "SGLT2 inhibitors real-world evidence Canada".

Format Requirements:

• Document: Word/LaTeX (Times New Roman 12pt, 1.5-line spacing).
• Core Materials:

- Ethical approval (for human/animal studies) + informed consent;
- Author contribution statement (CRediT format);
- Conflict of interest disclosure (including funding sources from Canadian agencies like CIHR).

• References: Vancouver format (max 60 entries; prioritize recent Canadian studies).

Costs:

• Subscription model: Free (no APC).
• Optional Open Access: CAD 2,200 (~USD 1,600) for OA publication; fee waivers available for researchers from low-income countries or Diabetes Canada members.

(2) Advanced Practical Tips

Topic Selection & Innovation:

1. Focus on Canadian-specific gaps: Indigenous diabetes prevalence, rural diabetes care access, or Canada’s national diabetes strategy outcomes.
2. For case reports: Highlight rarity in Canadian populations (e.g., "First report of diabetic foot osteomyelitis in Inuit patients in Nunavut").

Cover Letter Writing:

• Address the Editor-in-Chief by name (e.g., Dr. Jane Smith—check the journal’s Editorial Board page).
• 5-sentence template:

1. Background: "Diabetes affects 1 in 10 Canadians, with Indigenous populations at 3x higher risk (Diabetes Canada, 2024)."
2. Research Goal: "We aimed to evaluate the effectiveness of a community-based diabetes prevention program in rural Ontario."
3. Methods: "A 2-year prospective cohort study of 500 adults with prediabetes."
4. Key Findings: "The program reduced progression to Type 2 diabetes by 35% vs. standard care."
5. Fit: "Our study aligns with the journal’s mission to advance diabetes care in Canada; no prior submission elsewhere."

Review Response:

• Use the structure: "Question → Response → Modification Location".
• Example: If a reviewer asks for more Canadian subgroup data:

"Question: Could you add subgroup analysis for Indigenous participants?
Response: We added a subgroup of 80 Indigenous participants (Section 3.2, Table 3) showing a 40% risk reduction (vs. 32% for non-Indigenous).
Modification Location: Highlighted in yellow in the manuscript."

• Critical: Cite at least one recent Can J Diabetes paper in your response (e.g., "As noted in Smith et al. (2023) in this journal, Indigenous diabetes care requires tailored community interventions.").

4. Case Reference & Risk Alerts

Success Case

A team from the University of Toronto submitted a study on "Real-world effectiveness of GLP-1 agonists in Canadian seniors with Type 2 diabetes". Key steps to acceptance:
1. Cover letter emphasized Canadian relevance: "Our data from Ontario’s health insurance database (OHIP) fills a gap in senior diabetes management in Canada."
2. Added subgroup analysis for low-income seniors (a priority in Canadian healthcare policy).
3. Responded to reviewers by including cost-effectiveness data from the Canadian Institute for Health Information (CIHI).
Result: Accepted after 1 round of revisions (total time: 110 days).

High-Risk Warnings

1. Scope Misalignment: Submitting a global study without Canadian context is the #1 rejection reason (30% of 2024 rejections).
2. Format Errors: Missing ethical approval for Canadian clinical trials (mandatory for all human studies).
3. Innovation Gap: Case reports of common diabetes complications (e.g., diabetic retinopathy) are rarely accepted—focus on rare cases.

Adaptation Suggestions:

• For graduate students: Submit case reports or small-scale clinical studies (with Canadian data) to build publication experience.
• For clinicians: Submit real-world evidence from Canadian clinics to increase acceptance chances.

5. Summary & Toolkit

Core Summary:

The Canadian Journal of Diabetes is a reputable regional journal for diabetes research with a strong focus on Canadian clinical practice and public health. It’s an excellent choice for researchers targeting local impact or early-career professionals seeking their first peer-reviewed publication.

Practical Toolkit:

• Data Query:

- JCR: Clarivate Analytics Web of Science;
- 中科院分区: 中科院文献情报中心 WeChat Mini Program;
- Journal Guidelines: [Can J Diabetes Official Website](https://www.canadianjournalofdiabetes.ca/).

• Submission Aids:

- Reference Formatting: Mendeley (Vancouver template);
- Manuscript Editing: Grammarly (academic version) + Journal’s style guide;
- Citation Tracking: ResearchRabbit (follow recent Can J Diabetes publications).

• Support: Contact the journal’s editorial office (editor@canadianjournalofdiabetes.ca) for questions about Canadian relevance requirements.

Final Tip: Always highlight the Canadian connection in your submission—this is the key to standing out!

```

点击查看:Can J Diabetes最新影响因子与分区